Mission

The Mission of the Johns Hopkins Center for Tuberculosis Research (CTR) is to contribute to global tuberculosis control through a range of research and training initiatives in epidemiology, diagnostics, drug development, clinical trials, pathogenesis and basic biology. The CTR, founded in 1998, is comprised of a multi-disciplinary team of scientists working to combat Mycobacterium tuberculosis, a pathogen that causes 1.5 to 2 million deaths every year. Our faculty is drawn from the Schools of Medicine, Bloomberg School of Public Health and Nursing, with a research portfolio that is broad and interdisciplinary. Our major strengths are molecular biology, epidemiology, clinical trials, drug development and mathematical modeling; additional areas of emphasis include animal models, pathogenesis, vaccine development, behavioral research, immunology, and diagnostics.

While research is a primary focus, developing the next cadre of scientists who will contribute to future control efforts is also a major goal. Students from medicine, public health, and nursing have found that the range of topics and locations offer excellent training opportunities. With the slogan, “From bench to bedside and beyond,” the CTR covers everything from genetic epidemiology of TB to population-level studies that have played a major role in forming global policies for TB control.

Events

«

April 2017

»
S
M
T
W
T
F
S
·
·
·
·
·
·
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
·
·
·
·
·
·

Projects

Scale-up and implementation of TB diagnostics...

We are evaluating the implementation, cost-effectiveness, and potential epidemiological impact of scaling up Xpert across 19...

Read More

TBM-KIDS (India)

A phase 2 clinical trial of optimized treatment for pediatric tuberculous meningitis in India and Malawi

Read More